–
Eupraxia Pharmaceuticals Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY22 to FY25
millions USD
FY21:
FY22:
−14.4
FY23:
−20.7
FY24:
−30.0
FY25:
−28.6
Change from FY21 to FY25
millions USD
FY21:
−11.3
FY22:
9.83
FY23:
−0.07
FY24:
−0.08
FY25:
−0.59
Change from FY22 to FY25
millions USD
FY21:
–
FY22:
10.8
FY23:
21.1
FY24:
45.8
FY25:
76.1
(positive)
Change from FY21 to FY25
millions USD
FY21:
−11.8
FY22:
−14.6
FY23:
−20.8
FY24:
−30.1
FY25:
−29.1
All amounts in millions USD FY21: figures supplemented from Twelve Data because the SEC filings do not reach back this far.